---
figid: PMC8880564__pharmaceuticals-15-00246-sch001
figtitle: Design, Synthesis, and Biological Evaluation of a Novel VEGFR-2 Inhibitor
  Based on a 1,2,5-Oxadiazole-2-Oxide Scaffold with MAPK Signaling Pathway Inhibition
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
pmcid: PMC8880564
filename: pharmaceuticals-15-00246-sch001.jpg
figlink: /pmc/articles/PMC8880564/figure/pharmaceuticals-15-00246-sch001/
number: S1
caption: Synthesis of unexpected compounds 5a–d and target compounds 6a–h. (i) Ar-NHNH2;
  (ii) R2COOH; (iii) POCl3; (iv) p-aminophenol; (v) allyl bromide, EtOH, reflux, 45
  min.; (vi) NaNO2, HOAc, 25–70 °C, 1 h; (vii) 3-(((methylsulfonyl)oxy)methyl)-4-phenyl-1,2,5-oxadiazole
  2-oxide, NaOH, THF, reflux, 2 h.
papertitle: Design, Synthesis, and Biological Evaluation of a Novel VEGFR-2 Inhibitor
  Based on a 1,2,5-Oxadiazole-2-Oxide Scaffold with MAPK Signaling Pathway Inhibition.
reftext: Mater H. Mahnashi, et al. Pharmaceuticals (Basel). 2022 Feb;15(2):246.
year: '2022'
doi: 10.3390/ph15020246
journal_title: Pharmaceuticals
journal_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI
keywords: pyrazolo[3,4-d]pyrimidines | furoxan | VEGFR-2 | DAF-FM DA | MAPK | metastasis
  | apoptosis
automl_pathway: 0.7204561
figid_alias: PMC8880564__S1
figtype: Scheme
redirect_from: /figures/PMC8880564__S1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8880564__pharmaceuticals-15-00246-sch001.html
  '@type': Dataset
  description: Synthesis of unexpected compounds 5a–d and target compounds 6a–h. (i)
    Ar-NHNH2; (ii) R2COOH; (iii) POCl3; (iv) p-aminophenol; (v) allyl bromide, EtOH,
    reflux, 45 min.; (vi) NaNO2, HOAc, 25–70 °C, 1 h; (vii) 3-(((methylsulfonyl)oxy)methyl)-4-phenyl-1,2,5-oxadiazole
    2-oxide, NaOH, THF, reflux, 2 h.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - cn
  - Hn
  - ple
  - Eig71Ee
  - l(2)46Da
  - anon-48Ae
  - br
  - peb
  - vi
  - Sh
---
